Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Metformin in Li Fraumeni (MILI) Trial: A Phase II Randomised open-label cancer prevention study of Metformin in adults with Li Fraumeni Syndrome

MILI_Logo.png

Full Title

Metformin in Li Fraumeni (MILI) Trial: A Phase II Randomised open-label cancer prevention study of  Metformin in adults with Li Fraumeni Syndrome

Chief Investigator: Prof Sarah Blagden

Sponsor: University of Oxford

STATUS

Protocol currently under development.